LB Pharmaceuticals logo
LB Pharmaceuticals
LBRX | NASDAQ
Chart Builder DCF Calculator
$42.99
-$0.02 (-0.05%)
At close: Nov 16, 2026, 4:00 PM ET
$42.99
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

LB Pharmaceuticals Cash Flow Statement

Cash flow statement explained
TTM
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
-141.2M -85.69M -38.95M -25.21M -13.73M -24.36M -47.18M -58.03M -43.85M -16.15M
-53K 345K 324K 321K 236K 160K 87K 11K 6K 3K
11.14M 5.78M 1.22M 1.85M 1.85M 1.44M 1.45M 884K 412K 73K
-25.97M -25.86M -22.86M -15.35M -3.95M -14.25M -3.18M 5.98M 16.16M 6.35M
-3.67M 17.79M 4.68M 1.48M -1.34M 1.01M 2.67M 3.59M 1.92M 154K
– – – – – – – – – –
-9.53M -20.63M -17.63M -13.65M -4.12M -14.02M -2.96M 6.16M 16.16M 6.35M
-143.31M -82.4M -50.37M -35.21M -17.11M -35.77M -45.94M -47.39M -25.35M -9.57M
-505K -435K -63K -52K -12K -455K -505K -531K -88K -47K
– – – – – – – – – –
-166.14M -44.84M -44.84M -44.84M -44.84M – -3.73M -29.75M -29.75M -26.02M
22.01M – – 5M 5M 34.32M 34.32M 29.32M – –
3K 452K – – – – 10.66M 10.66M 10.66M –
-144.64M -44.82M -44.9M -39.89M -39.85M 33.86M 40.74M 9.7M -19.18M -26.06M
– – – – – – – – – –
– – – – – – – – – –
– – – – – – – – – –
140.9M 303.47M 303.49M 303.49M 303.49M – 3K -1.71M -1.71M -1.71M
233.56M 396.37M 396.39M 302.56M 303.73M 20K 23K 38.32M 38.3M 38.29M
-54.66M 268.9M 300.86M 227.21M 246.78M -1.89M -5.18M 624K -6.23M 2.66M
-143.82M -82.83M -50.43M -35.26M -17.12M -36.22M -46.45M -47.92M -25.44M -9.62M
-154.96M -88.61M -51.65M -37.11M -18.97M -37.67M -47.89M -48.8M -25.85M -9.69M
-239K -169K -81K -70K -35K -38K -32K n/a n/a n/a
-266K -266K 18K 18K -420K -458K -520K n/a n/a n/a
-143.55M -82.56M -50.45M -35.28M -39.18M -51.58M -55.55M n/a n/a n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.